Publications by authors named "Gabriel Barragan"

Claim this Profile
P
PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function.
Gengwen Tian, Gabriel A Barragan, Hangjin Yu, Claudia Martinez-Amador, Akshaya Adaikkalavan

Cancer Immunol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15.
Gengwen Tian, Amy N Courtney, Hangjin Yu, Saleh Bhar, Xin Xu

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
Elisa Landoni, Mark G Woodcock, Gabriel Barragan, Gabriele Casirati, Vincenzo Cinella

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Andras Heczey, Xin Xu, Amy N Courtney, Gengwen Tian, Gabriel A Barragan

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
Elisa Landoni, Mark G Woodcock, Gabriel Barragan, Gabriele Casirati, Vincenzo Cinella

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining chimeric antigen receptors via barcoded protein domain combination pooled screening.
Xavier Rios, Osmay Pardias, Marc A Morales, Pradyot Bhattacharya, Yibin Chen, Gabriel A Barragan

Mol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Andras Heczey, Xin Xu, Amy N Courtney, Gengwen Tian, Gabriel A Barragan

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma.
Julie A Tomolonis, Xin Xu, Kshiti H Dholakia, Chunchao Zhang, Linjie Guo

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.
Ho Ngai, Gabriel A Barragan, Gengwen Tian, Julien C Balzeau, Chunchao Zhang

Cancer Immunol Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced Persistence and Antitumor Activity against Neuroblastoma.
Xin Xu, Wei Huang, Andras Heczey, Daofeng Liu, Linjie Guo, Gabriel A Barragan

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis